• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Demographic considerations in tacrolimus pharmacokinetics.

作者信息

Fitzsimmons W E, Bekersky I, Dressler D, Raye K, Hodosh E, Mekki Q

机构信息

Deerfield, Illinois, USA.

出版信息

Transplant Proc. 1998 Jun;30(4):1359-64. doi: 10.1016/s0041-1345(98)00275-9.

DOI:10.1016/s0041-1345(98)00275-9
PMID:9636552
Abstract
摘要

相似文献

1
Demographic considerations in tacrolimus pharmacokinetics.
Transplant Proc. 1998 Jun;30(4):1359-64. doi: 10.1016/s0041-1345(98)00275-9.
2
Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.肾移植术后第一年影响他克莫司药代动力学的因素。欧洲他克莫司多中心肾脏研究组
Transplant Proc. 1998 Jun;30(4):1261-3. doi: 10.1016/s0041-1345(98)00234-6.
3
Pharmacokinetics of tacrolimus in paediatric renal transplant recipients.他克莫司在小儿肾移植受者中的药代动力学
Transplant Proc. 2002 Aug;34(5):1948-50. doi: 10.1016/s0041-1345(02)03133-0.
4
Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.评估新型EMIT酶免疫测定法用于测定肾、心脏和肝移植受者全血他克莫司浓度的情况。
Transplant Proc. 2002 Nov;34(7):2988-90. doi: 10.1016/s0041-1345(02)03510-8.
5
Clinical influencing factors for daily dose, trough level, and relative clearance of tacrolimus in renal transplant recipients.肾移植受者中他克莫司每日剂量、谷浓度及相对清除率的临床影响因素
Transplant Proc. 2000 Nov;32(7):1689-92. doi: 10.1016/s0041-1345(00)01413-5.
6
Pharmacokinetics of FK 506 in living-related liver transplantation.FK506在亲属活体肝移植中的药代动力学
Transplant Proc. 1996 Apr;28(2):1005.
7
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.肾移植受者中他克莫司初始免疫抑制的药代动力学
Transplant Proc. 2001 May;33(3):2127-8. doi: 10.1016/s0041-1345(01)01970-4.
8
Optimal time points for the prediction of the area-under-the-curve in liver transplant patients receiving tacrolimus.预测接受他克莫司治疗的肝移植患者曲线下面积的最佳时间点。
Transplant Proc. 1998 Jun;30(4):1460-1. doi: 10.1016/s0041-1345(98)00315-7.
9
The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.C4和AUC0-4在稳定期肾移植患者他克莫司监测中的作用。
Transplant Proc. 2002 Dec;34(8):3173-5. doi: 10.1016/s0041-1345(02)03684-9.
10
Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
J Chemother. 1998 Apr;10(2):176-8. doi: 10.1179/joc.1998.10.2.176.

引用本文的文献

1
Impact of Switching From Immediate- or Prolonged-Release to Once-Daily Extended-Release Tacrolimus (LCPT) on Tremor in Stable Kidney Transplant Recipients: The Observational ELIT Study.从即时或延长释放改为每日一次的延长释放他克莫司（LCPT）对稳定肾移植受者震颤的影响：观察性 ELIT 研究。
Transpl Int. 2024 Apr 17;37:11571. doi: 10.3389/ti.2024.11571. eCollection 2024.
2
Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.群体药代动力学模型的适应性调整以指导心脏移植受者的他克莫司治疗。
Br J Clin Pharmacol. 2023 Mar;89(3):1162-1175. doi: 10.1111/bcp.15566. Epub 2022 Nov 6.
3
Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients.
细胞色素P450 3A5基因多态性对肾移植受者他克莫司药代动力学的影响。
Korean J Transplant. 2020 Mar 31;34(1):24-30. doi: 10.4285/kjt.2020.34.1.24.
4
Tacrolimus Dose-Conversion Ratios Based on Switching of Formulations for Patients with Solid Organ Transplants.基于实体器官移植患者制剂转换的他克莫司剂量转换比率
Can J Hosp Pharm. 2021 Fall;74(4):317-326. doi: 10.4212/cjhp.v74i4.3193.
5
Beyond Single Nucleotide Polymorphisms: Composite and Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients.超越单核苷酸多态性：黑人和白人肾移植受者中他克莫司药代动力学的复合和单倍型关联
Front Genet. 2020 Aug 11;11:889. doi: 10.3389/fgene.2020.00889. eCollection 2020.
6
Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.肝、肾和心脏移植受者中速释和缓释他克莫司制剂的群体药代动力学。
Br J Clin Pharmacol. 2019 Aug;85(8):1692-1703. doi: 10.1111/bcp.13952. Epub 2019 Jun 7.
7
Overview of extended release tacrolimus in solid organ transplantation.实体器官移植中缓释他克莫司概述
World J Transplant. 2016 Mar 24;6(1):144-54. doi: 10.5500/wjt.v6.i1.144.
8
Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.非裔美国肾移植受者中基于基因型的他克莫司给药方案
Pharmacogenomics J. 2017 Jan;17(1):61-68. doi: 10.1038/tpj.2015.87. Epub 2015 Dec 15.
9
Association of Extrarenal Adverse Effects of Posttransplant Immunosuppression With Sex and ABCB1 Haplotypes.移植后免疫抑制的肾外不良反应与性别及ABCB1单倍型的关联
Medicine (Baltimore). 2015 Sep;94(37):e1315. doi: 10.1097/MD.0000000000001315.
10
Pharmacokinetic differences corroborate observed low tacrolimus dosage in Native American renal transplant patients.药代动力学的差异证实了在美洲原住民肾移植患者中观察到的低他克莫司剂量。
Drug Metab Dispos. 2011 Nov;39(11):2017-9. doi: 10.1124/dmd.111.041350. Epub 2011 Aug 17.